Number of the records: 1  

Coxiella burnetii immunogenic proteins as a basis for new Q fever diagnostic and vaccine development

  1. 1.
    SYSNO ASEP0506532
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleCoxiella burnetii immunogenic proteins as a basis for new Q fever diagnostic and vaccine development
    Author(s) Gerlach, C. (DE)
    Škultéty, L'udovít (MBU-M) ORCID, RID
    Henning, K. (DE)
    Neubauer, H. (DE)
    Mertens, K. (DE)
    Source TitleActa virologica - ISSN 0001-723X
    Roč. 6, č. 3 (2017), s. 377-390
    Number of pages14 s.
    Languageeng - English
    CountrySK - Slovakia
    KeywordsCoxiella burnetii ; proteomic analysis ; immunoreactive proteins
    Subject RIVEE - Microbiology, Virology
    OECD categoryMicrobiology
    Method of publishingOpen access
    Institutional supportMBU-M - RVO:61388971
    UT WOS000411298700021
    EID SCOPUS85028608955
    DOI10.4149/av_2017_320
    AnnotationCoxiella burnetii is the etiological agent of the zoonosis Q fever, which can cause an acute or a chronic, life-threatening disease in humans. It presents a highly stable cell form, which persists in the environment and is transmitted via contaminated aerosols. Ruminants are considered as the main reservoir for human infections but are usually asymptomatic. Subclinical infection in these animals and the occurrence of serologically negative shedders hamper the identification of infected animals with the currently used diagnostic techniques. This suboptimal sensitivity limits reliable identification of infected animals as well as the well-timed implementation of countermeasures. This review summarizes compounds, focusing on C. burnetii seroreactive proteins, which were discovered in recent immunoproteomic studies. We analyzed these proteins regarding their localization, function, frequency of citation, differences seen in various host species as well as sensitivity and specificity. Finally, proteins useful for the development of new diagnostic test systems as well as subunit vaccines were discussed.
    WorkplaceInstitute of Microbiology
    ContactEliška Spurná, eliska.spurna@biomed.cas.cz, Tel.: 241 062 231
    Year of Publishing2020
    Electronic address85028608955
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.